Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Not only does the United States spend the largest percent of its Gross Domestic Product on healthcare compared to other countries, but radiologists are also paid more here, by comparison, to anywhere else in the world. Research released this week from the United Kingdom takes a look at how countries value healthcare and where radiologists fall in compensation compared with other healthcare professionals. Look for the story later this week.
For more radiology compensation coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Point-of-care ultrasound continues to grow in popularity, meaning that providers other than radiologists are becoming familiar with – and comfortable using – the modality. This week, Diagnostic Imaging speaks with two emergency providers about what non-radiologists need to know about the use of bedside renal ultrasound. Take a look at the story later this week to help better inform your non-imaging colleagues about how they can best use this tool.
For more coverage of renal imaging, click here.
Tomosynthesis has proven its value in better breast cancer detection. But, how is it being used across healthcare settings that may not have equivalent resources and expertise? This week, Diagnostic Imaging talks with Amy Patel, M.D., medical director of the Women’s Imaging Center at Liberty Hospital, about the impact tomosynthesis makes when used in conjunction with digital mammography in both academic and community settings. Keep your eyes open for the interview later this week.
For additional coverage on tomosynthesis, click here.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.